De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cardinal Health Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Cardinal Health is de winst gegroeid met een gemiddeld jaarlijks percentage van 37.5%, terwijl de Healthcare industrie de winst jaarlijks groeide met 6.2%. De inkomsten zijn gegroeid met een gemiddelde van 9.4% per jaar.
Belangrijke informatie
37.5%
Groei van de winst
37.6%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | 9.4% |
Rendement op eigen vermogen | n/a |
Nettomarge | 0.4% |
Volgende winstupdate | 01 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
Sep 24Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching
Sep 17Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Opbrengsten en kosten
Hoe Cardinal Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 226,827 | 852 | 5,000 | 0 |
31 Mar 24 | 220,572 | 552 | 5,029 | 0 |
31 Dec 23 | 216,148 | 639 | 4,926 | 0 |
30 Sep 23 | 210,172 | 156 | 4,834 | 0 |
30 Jun 23 | 204,979 | 330 | 4,800 | 0 |
31 Mar 23 | 198,662 | 463 | 4,722 | 0 |
31 Dec 22 | 193,011 | -1,273 | 4,680 | 0 |
30 Sep 22 | 186,999 | -1,094 | 4,640 | 0 |
30 Jun 22 | 181,326 | -938 | 4,512 | 0 |
31 Mar 22 | 176,847 | -955 | 4,531 | 0 |
31 Dec 21 | 171,286 | 555 | 4,514 | 0 |
30 Sep 21 | 167,370 | 1,135 | 4,510 | 0 |
30 Jun 21 | 162,467 | 611 | 4,533 | 0 |
31 Mar 21 | 156,570 | 1,151 | 4,541 | 0 |
31 Dec 20 | 156,452 | 1,382 | 4,586 | 0 |
30 Sep 20 | 154,646 | 973 | 4,602 | 0 |
30 Jun 20 | 152,922 | -3,696 | 4,572 | 0 |
31 Mar 20 | 153,586 | -4,158 | 4,600 | 0 |
31 Dec 19 | 149,657 | -4,212 | 4,531 | 0 |
30 Sep 19 | 147,662 | -4,152 | 4,432 | 0 |
30 Jun 19 | 145,534 | 1,363 | 4,480 | 0 |
31 Mar 19 | 143,530 | 3 | 4,586 | 0 |
31 Dec 18 | 141,935 | -39 | 4,622 | 0 |
30 Sep 18 | 139,381 | 734 | 4,689 | 0 |
30 Jun 18 | 136,809 | 256 | 4,596 | 0 |
31 Mar 18 | 134,426 | 1,696 | 4,308 | 0 |
31 Dec 17 | 132,614 | 1,823 | 4,137 | 0 |
30 Sep 17 | 130,578 | 1,094 | 3,917 | 0 |
30 Jun 17 | 129,976 | 1,288 | 3,775 | 0 |
31 Mar 17 | 128,394 | 1,346 | 3,762 | 0 |
31 Dec 16 | 127,236 | 1,351 | 3,715 | 0 |
30 Sep 16 | 125,530 | 1,353 | 3,726 | 0 |
30 Jun 16 | 121,546 | 1,427 | 3,648 | 0 |
31 Mar 16 | 117,710 | 1,387 | 3,525 | 0 |
31 Dec 15 | 112,423 | 1,366 | 3,414 | 0 |
30 Sep 15 | 106,516 | 1,329 | 3,307 | 0 |
30 Jun 15 | 102,531 | 1,212 | 3,240 | 0 |
31 Mar 15 | 97,877 | 1,154 | 3,188 | 0 |
31 Dec 14 | 93,928 | 1,104 | 3,121 | 0 |
30 Sep 14 | 90,631 | 1,089 | 3,071 | 0 |
30 Jun 14 | 91,084 | 1,163 | 3,028 | 0 |
31 Mar 14 | 93,610 | 343 | 3,009 | 0 |
31 Dec 13 | 96,735 | 374 | 2,984 | 0 |
Kwaliteitswinsten: CAH heeft een grote eenmalige verlies van $903.0M wat gevolgen heeft voor de financiële resultaten van de laatste 12 maanden tot 30th June, 2024.
Groeiende winstmarge: De huidige netto winstmarges (0.4%) CAH } zijn hoger dan vorig jaar (0.2%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van CAH is de afgelopen 5 jaar aanzienlijk gegroeid met 37.5% per jaar.
Versnelling van de groei: De winstgroei van CAH over het afgelopen jaar ( 158.2% ) overtreft het 5-jarig gemiddelde ( 37.5% per jaar).
Winst versus industrie: De winstgroei CAH over het afgelopen jaar ( 158.2% ) overtrof de Healthcare -sector 8%.
Rendement op eigen vermogen
Hoge ROE: De schulden van CAH zijn groter dan de activa, dus het is lastig om het rendement op het eigen vermogen te berekenen.